Target type: biologicalprocess
Any process that modulates the frequency, rate, or extent of neutrophil chemotaxis. Neutrophil chemotaxis is the directed movement of a neutrophil cell, the most numerous polymorphonuclear leukocyte found in the blood, in response to an external stimulus, usually an infection or wounding. [GOC:dph, GOC:tb]
Neutrophil chemotaxis, the directed migration of neutrophils towards a chemical gradient, is a fundamental process in innate immunity. It involves a complex interplay of signaling pathways, cytoskeletal rearrangements, and adhesion events.
1. **Chemoattractant Sensing and Signal Transduction:**
- Neutrophils express a diverse array of receptors, including G protein-coupled receptors (GPCRs) like formyl peptide receptors (FPRs), chemokine receptors (CXCRs), and complement receptors (CRs), which bind to chemoattractants.
- Binding of chemoattractants to their receptors triggers a signaling cascade involving G proteins, phospholipase C (PLC), diacylglycerol (DAG), inositol triphosphate (IP3), and intracellular calcium release.
2. **Polarization and Directional Migration:**
- The signaling cascade leads to the polarization of the neutrophil, with the leading edge becoming enriched in actin polymerization and the trailing edge enriched in myosin.
- This polarization is driven by the assembly of signaling complexes at the leading edge, including Rac1 and PI3K, which regulate actin polymerization and membrane ruffling.
- Simultaneously, the trailing edge is stabilized by RhoA signaling, promoting actomyosin contraction.
3. **Adhesion and Detachment:**
- Neutrophils adhere to the endothelium via integrins, which are activated by inside-out signaling triggered by chemoattractants.
- This adhesion allows neutrophils to crawl along the vascular wall, following the chemoattractant gradient.
- Detachment from the endothelium is facilitated by the release of matrix metalloproteinases (MMPs), which degrade the extracellular matrix.
4. **Chemotaxis and Resolution:**
- Neutrophils follow the chemoattractant gradient, navigating through tissue and reaching the site of infection or injury.
- Upon reaching the target, neutrophils release antimicrobial peptides, reactive oxygen species, and other inflammatory mediators to fight off pathogens.
- The resolution of the inflammatory response involves the apoptosis of neutrophils and their clearance by macrophages.'
"
Protein | Definition | Taxonomy |
---|---|---|
Nucleotide-binding oligomerization domain-containing protein 2 | A nucleotide-binding oligomerization domain-containing protein 2 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q9HC29] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
paclitaxel | Taxus: Genus of coniferous yew trees or shrubs, several species of which have medicinal uses. Notable is the Pacific yew, Taxus brevifolia, which is used to make the anti-neoplastic drug taxol (PACLITAXEL). | taxane diterpenoid; tetracyclic diterpenoid | antineoplastic agent; human metabolite; metabolite; microtubule-stabilising agent |
docetaxel anhydrous | docetaxel anhydrous : A tetracyclic diterpenoid that is paclitaxel with the N-benzyloxycarbonyl group replaced by N-tert-butoxycarbonyl, and the acetoxy group at position 10 replaced by a hydroxy group. Docetaxel: A semisynthetic analog of PACLITAXEL used in the treatment of locally advanced or metastatic BREAST NEOPLASMS and NON-SMALL CELL LUNG CANCER. | secondary alpha-hydroxy ketone; tetracyclic diterpenoid | antimalarial; antineoplastic agent; photosensitizing agent |
muramyl dipeptide | glycopeptide | immunological adjuvant | |
3-methyl-7-pentyl-8-(2-phenylethylthio)purine-2,6-dione | oxopurine | ||
3-methyl-7-(phenylmethyl)-8-(propan-2-ylthio)purine-2,6-dione | oxopurine | ||
1-(4-methylphenyl)sulfonyl-2-benzimidazolamine | sulfonamide | ||
1-(4-chlorophenyl)sulfonyl-2-benzimidazolamine | sulfonamide | ||
1-(benzenesulfonyl)-2-benzimidazolamine | sulfonamide | ||
1-(4-nitrophenyl)sulfonyl-2-benzimidazolamine | sulfonamide | ||
pd 166285 | |||
1-(4-methoxyphenyl)sulfonyl-2-benzimidazolamine | sulfonamide | ||
5,6-dimethyl-1-(4-methylphenyl)sulfonyl-2-benzimidazolamine | sulfonamide |